These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33559226)

  • 1. Further benefits of imminent death donation.
    Molchan K; Potter J
    Am J Transplant; 2021 Sep; 21(9):3199-3200. PubMed ID: 33559226
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: Kidney Exchange to Overcome Financial Barriers to Kidney Transplantation.
    Baines LS; Jindal RM
    Am J Transplant; 2017 Oct; 17(10):2742. PubMed ID: 28432723
    [No Abstract]   [Full Text] [Related]  

  • 3. Barriers to live and deceased kidney donation by patients with chronic neurological diseases: Implications for donor selection, donation timing, logistics, and regulatory compliance.
    Troppmann C; Santhanakrishnan C; Sageshima J; McVicar J; Perez R
    Am J Transplant; 2019 Aug; 19(8):2168-2173. PubMed ID: 30582272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global kidney exchange: Financially incompatible pairs are not transplantable compatible pairs.
    Rees MA; Paloyo SR; Roth AE; Krawiec KD; Ekwenna O; Marsh CL; Wenig AJ; Dunn TB
    Am J Transplant; 2017 Oct; 17(10):2743-2744. PubMed ID: 28758331
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential yield of imminent death kidney donation.
    Denu RA; Mendonca EA; Fost N
    Am J Transplant; 2018 Feb; 18(2):486-491. PubMed ID: 28975705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired Donation.
    Gill JS; Tinckam K; Fortin MC; Rose C; Shick-Makaroff K; Young K; Lesage J; Cole EH; Toews M; Landsberg DN; Gill J
    Am J Transplant; 2017 Jul; 17(7):1723-1728. PubMed ID: 28321984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESRD in Living Donors Before 1987: Obtaining Waitlist Priority.
    Hays R; Lillesand C; Mandelbrot DA
    Am J Transplant; 2017 Dec; 17(12):3260-3261. PubMed ID: 28544384
    [No Abstract]   [Full Text] [Related]  

  • 8. People should not be banned from transplantation only because of their country of origin.
    Roth AE; Krawiec KD; Paloyo S; Ekwenna O; Marsh CL; Wenig AJ; Dunn TB; Rees MA
    Am J Transplant; 2017 Oct; 17(10):2747-2748. PubMed ID: 28862804
    [No Abstract]   [Full Text] [Related]  

  • 9. A Potential Solution to Make the Best Use of a Living Donor-Deceased Donor List Exchange.
    Kute VB; Patel HV; Shah PR; Modi PR; Shah VR; Trivedi HL
    Am J Transplant; 2016 Dec; 16(12):3580. PubMed ID: 27454322
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial Neutrality for Living Organ Donors: Reasoning, Rationale, Definitions, and Implementation Strategies.
    Hays R; Rodrigue JR; Cohen D; Danovitch G; Matas A; Schold J; LaPointe Rudow D
    Am J Transplant; 2016 Jul; 16(7):1973-81. PubMed ID: 27037542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open dialogue between professionals with different opinions builds the best policy.
    Marino IR; Roth AE; Rees MA; Doria C
    Am J Transplant; 2017 Oct; 17(10):2749. PubMed ID: 28862794
    [No Abstract]   [Full Text] [Related]  

  • 12. A liver for a kidney: Ethics of trans-organ paired exchange.
    Samstein B; de Melo-Martin I; Kapur S; Ratner L; Emond J
    Am J Transplant; 2018 May; 18(5):1077-1082. PubMed ID: 29442420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime Insurance Benefit for Living Donors: Is It Necessary and Could It Be Coercive?
    Gibney EM
    Am J Transplant; 2016 Jan; 16(1):7-8. PubMed ID: 26639192
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical principles governing organ transplantation apply to paired exchange programs.
    Flechner SM; Cooper M; Waterman A; Kennealey P; Redfield R; Verbesey J
    Am J Transplant; 2020 Jun; 20(6):1756-1757. PubMed ID: 32277552
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of the israeli transplantation law on the socio-demographic profile of living kidney donors.
    Boas H; Mor E; Michowitz R; Rozen-Zvi B; Rahamimov R
    Am J Transplant; 2015 Apr; 15(4):1076-80. PubMed ID: 25737018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.
    Hays R; Gordon EJ; Ison MG; LaPointe Rudow D
    Am J Transplant; 2019 Dec; 19(12):3233-3239. PubMed ID: 31338956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Paired-Donation Program Versus Global Kidney Exchange in India.
    Kute V; Jindal RM; Prasad N
    Am J Transplant; 2017 Oct; 17(10):2740-2741. PubMed ID: 28432744
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving OPO performance through national data availability.
    Doby BL; Boyarsky BJ; Gentry S; Segev DL
    Am J Transplant; 2019 Oct; 19(10):2675-2677. PubMed ID: 31219210
    [No Abstract]   [Full Text] [Related]  

  • 19. Living and deceased organ donation should be financially neutral acts.
    Delmonico FL; Martin D; Domínguez-Gil B; Muller E; Jha V; Levin A; Danovitch GM; Capron AM
    Am J Transplant; 2015 May; 15(5):1187-91. PubMed ID: 25833381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to "Public attitude to imminent death donation".
    Galvan NTN; Rath S; Washburn L; Moolchandani P; Goss J
    Am J Transplant; 2021 Sep; 21(9):3202-3203. PubMed ID: 34043879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.